Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook 
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours 
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings 
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy 
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance 
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance 
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth 
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition 
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
Canada blocked bulk exports of prescription drugs to the US as it would cause or worsen a drug shortage at home.
The said importation from Canada is President Donald Trump's strategy of lowering some drug prices in the US, which he touted in his debate with President-elect Joe Biden.
Many Canadian drug suppliers opposed Trump's plan as it could lead to shortages,
The “Importation Prescription Drugs” rule in the US would allow licensed US pharmacists or wholesalers to import in bulk certain prescription drugs intended for the Canadian market.
According to Canada's Health Minister Patty Hajdu, companies will be required to provide information to assess existing or potential shortages, which could be as quick as within 24 hours if there is a serious or imminent health risk.
Hajdu emphasized the need for vigilance in maintaining the national drug supply noting that Canada is a small market, representing 2 percent of global drug sales, that sources 68 percent of its drugs internationally.
Canadian Prime Minister Justin Trudeau said in September that his priority was protecting the needs of Canadians in terms of pharmaceutical supplies.
